| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 09/19/1992 | WO1992016658A1 Response element compositions and assays employing same |
| 09/19/1992 | WO1992016640A1 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2100582A1 Response element compositions and assays employing same |
| 09/19/1992 | CA2063230A1 Cholesterol lowering agents |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015689A1 Expression of recombinant proteins in attenuated bacteria |
| 09/17/1992 | WO1992015688A1 Production of recombinant proteins |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015673A1 Cloning and expression of renilla luciferase |
| 09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015195A1 Insecticidally effective peptides |
| 09/17/1992 | DE4204568A1 Magneto=optical disc with two films for write and read capability - in which film materials have different Curie temperatures and Kerr rotary angles |
| 09/17/1992 | CA2103901A1 Insecticidally effective peptides isolatable from diguetia spider venom |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | EP0504043A1 Cosmetic composition containing phospholipid transfer proteins |
| 09/16/1992 | EP0503950A2 Method of purifying recombinant hepatitis B virus surface proteins from recombinant cells |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503297A1 GLIA activating factor and its production |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0503045A1 Cloning cartridges and expression vectors in gram-negative bacteria |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0494207A4 Thermostable purified endoglucanases from thermophilic bacterium acidothermus cellulolyticus |
| 09/16/1992 | EP0267224B1 Process for the production of a polypeptide |
| 09/16/1992 | EP0131624B1 Plasmids for transforming plant cells |
| 09/16/1992 | CN1064504A Method for producing kanglemycin c |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2062460A1 A method of stabilizing recombinant hepatitis b virus surface proteins from recombinant host cells |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016559A1 The trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | US5147860 Tan-1120, its derivatives, production and use thereof |
| 09/15/1992 | US5147858 Acidic polycyclic ether useful as an anticoccidial agent and as a growth promotant |
| 09/15/1992 | US5147800 Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria |
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |
| 09/15/1992 | US5147788 Baculovirus vectors and methods of use |
| 09/15/1992 | US5147640 Strains of bacillus thuringiensis insecticidal compositions containing the same |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA2105877A1 Tgf-.beta.1/.beta.2: novel chimeric transforming growth factor-beta |
| 09/15/1992 | CA1307484C Method for culturing recombinant cells |
| 09/15/1992 | CA1307483C Process for producing protein a and composition thereof |
| 09/15/1992 | CA1307482C Vectors and expression sequences for production of polypeptides |
| 09/15/1992 | CA1307481C Gal operon of streptomyces |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/13/1992 | WO1992016562A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105980A1 Humanised antibodies having modified allotypic determinants |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | WO1992015692A1 Novel plasmid |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502718A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502637A2 Vector |
| 09/09/1992 | EP0502607A1 Thymopoietin |
| 09/09/1992 | EP0502553A2 Peptide fragment from human villin and antibody thereto |
| 09/09/1992 | EP0502550A1 Colominic acid and partial hydrolysis products of colominic acid for the preparation of medicaments for the treatment of hepatitis, nephritis and arthritis |
| 09/09/1992 | EP0502525A1 Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide and R-(-)-2,2-dimethylcyclopropanecarboxylic acid |
| 09/09/1992 | EP0502524A1 Microbiological process for terminal hydroxylation of ethyl-groups on aromatic 5- or 6-membered heterocycles |
| 09/09/1992 | EP0502496A2 Novel heparitinase, process for producing the same and bacteria producing the same |
| 09/09/1992 | EP0502416A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 09/09/1992 | EP0502188A1 Cloned glutamic acid decarboxylase |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502146A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEIN gE |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502105A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
| 09/09/1992 | EP0502099A1 Chimeric proteins |
| 09/09/1992 | EP0494931A4 Monoclonal antibodies to segments of hiv-1 reverse transcriptase |
| 09/09/1992 | EP0473716A4 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 09/09/1992 | CN1064309A Compact detergent compositions with high activity cellulase |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/09/1992 | CA2082407A1 Plasmid |
| 09/08/1992 | US5145778 Heparinase produced by microorganism belonging to the genus bacillus |
| 09/08/1992 | US5145773 Contact with monoclonal antibodies to form antigen-antibody complex |
| 09/08/1992 | CA2062370A1 Pharmaceutical preparation |
| 09/08/1992 | CA2062357A1 Process for terminal hydroxylation of ethyl groups on aromatic 5-or 6-ring heterocycles |
| 09/08/1992 | CA1307256C Bbm-1675c and d antitumor antibiotics |
| 09/08/1992 | CA1307223C Preparation of clavulanic acid and its salts and esters |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/08/1992 | CA1307217C Monoclonal antibodies specific for eikenella corrodens |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/05/1992 | CA2061862A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/03/1992 | WO1992014848A1 Biological processes for recovering heavy metals |
| 09/03/1992 | WO1992014833A1 Cell-free and whole cell ice nucleators and process for their production |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014815A1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014737A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 09/03/1992 | CA2106099A1 Cultures of permanent lines of human promyelocyte cells and their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | EP0501921A2 Process of genetic manipulation of Myxobacteria |
| 09/02/1992 | EP0501914A1 Improved yeast vectors |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501779A1 Antibodies reactive with human cytosolic phospholipase A2 |
| 09/02/1992 | EP0501765A1 Method of producing D-ribose |
| 09/02/1992 | EP0501692A2 Fermentation processes for the production of peptides by a host |
| 09/02/1992 | EP0501650A2 Bacillus thuringiensis genes encoding novel coleopteranactive protein toxins |